IDEAYA Biosciences (IDYA) Equity Average: 2019-2025
Historic Equity Average for IDEAYA Biosciences (IDYA) over the last 7 years, with Sep 2025 value amounting to $1.0 billion.
- IDEAYA Biosciences' Equity Average fell 2.86% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year decrease of 2.86%. This contributed to the annual value of $840.1 million for FY2024, which is 73.12% up from last year.
- Per IDEAYA Biosciences' latest filing, its Equity Average stood at $1.0 billion for Q3 2025, which was up 3.42% from $991.9 million recorded in Q2 2025.
- IDEAYA Biosciences' Equity Average's 5-year high stood at $1.1 billion during Q4 2024, with a 5-year trough of $215.7 million in Q1 2021.
- Over the past 3 years, IDEAYA Biosciences' median Equity Average value was $933.5 million (recorded in 2024), while the average stood at $797.8 million.
- Its Equity Average has fluctuated over the past 5 years, first skyrocketed by 127.79% in 2024, then fell by 2.86% in 2025.
- Quarterly analysis of 5 years shows IDEAYA Biosciences' Equity Average stood at $309.6 million in 2021, then climbed by 16.00% to $359.1 million in 2022, then surged by 57.21% to $564.6 million in 2023, then spiked by 98.34% to $1.1 billion in 2024, then dropped by 2.86% to $1.0 billion in 2025.
- Its Equity Average stands at $1.0 billion for Q3 2025, versus $991.9 million for Q2 2025 and $1.0 billion for Q1 2025.